Cardina Health's trading volume on March 4th was $375 million, a 30.59% decrease compared to the previous trading day.

robot
Abstract generation in progress

On March 4, 2026, health and nursing products distributor company Kadin(a) Health (CAH) had transaction value of $375 million, ranking 332nd among U.S. stocks that day; transaction value decreased by 30.59% from the previous day, and trading volume was 1.6757 million shares that day.

Kadin(a) Health (CAH) fell 1.40% on March 4, 2026, to $223.18. Over the past 5 trading days, the stock is down 1.33%, the entire month of March is down 2.64%, year-to-date is up 8.60%, and over the past 52 weeks is up 76.69%.

*If the company has been listed for less than 52 weeks, then the 52-week return/loss is the return/loss since listing (the same applies to cases where the listing period is less than 1 month or fewer than 5 trading days)

Kadin(a) Health (CAH) Transaction value/ USD Change in transaction value vs. yesterday Trading volume
March 4, 2026 $375 million -30.59% 1.6757 million
March 3, 2026 $540 million 34.01% 2.3983 million
March 2, 2026 $403 million -14.84% 1.7511 million
February 27, 2026 $473 million 78.24% 2.0669 million
February 26, 2026 $265 million 33.55% 1.1671 million

Kadin(a) Health released its 2026 fiscal mid-year report on February 5, 2026. Revenue from July 1, 2025 to December 31, 2025 was $129.636 billion, up 20.55% year over year, and net profit was $925 million, up 13.08% year over year.

Kadin(a) Health Group is an Ohio-based company founded in 1979. It is a global integrated healthcare services and products company that provides customized solutions to hospitals, healthcare systems, pharmacies, outpatient surgery centers, clinical laboratories, physician offices, and home patients. The company offers pharmaceuticals and medical products, along with cost-effective solutions to improve supply chain efficiency. The company connects patients, providers, payers, pharmacists, and manufacturers to enable integrated care coordination and better patient management. The company manages its business and reports its financial performance in two segments: pharmaceuticals and healthcare.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin